`

Monday, 20 January 2020

Pharma/BioPharma News

  • Alembic Pharma gets USFDA approval for generic Clobex spray

    Pharma/BioPharma |  News | 0 Comment | 07 Oct, 2019

    Alembic Pharmaceuticals Limited, a vertically integrated research and development pharmaceutical company, announces its joint venture Aleor Dermaceuticals receives Approval from US Food &am...Read more

  • Lupin launches Mycophenolate Mofetil Capsules USP

    Pharma/BioPharma |  News | 0 Comment | 04 Oct, 2019

    Pharma major Lupin Limited (Lupin) announced the launch of Mycophenolate Mofetil Capsules USP, 250 mg. Lupin’s&nb...Read more

  • Biocon, Mylan launch Semglee in Australia

    Pharma/BioPharma |  News | 0 Comment | 03 Oct, 2019

    Biocon Ltd and Mylan N.V.  have announced the launch of Semglee® (insulin glargine solution for injection 100 IU/mL in a 3mL pre-filled pen), the first insulin glargine biosimilar ...Read more

  • AstraZeneca selects N-SIDE suite for clinical trials

    Pharma/BioPharma |  News | 0 Comment | 01 Oct, 2019

    N-SIDE, provider of innovative software and strategic consulting services, announced that AstraZeneca has signed an agreement to implement the N-SIDE Suite for Clinical Trials. Within the s...Read more

  • Lupin launches Sildenafil Tablets USP

    Pharma/BioPharma |  News | 0 Comment | 30 Sep, 2019

    Pharma major Lupin Limited (Lupin) announced the launch of Sildenafil Tablets USP, 25 mg, 50 mg, and 100 mg, having received an approval from the United States Food and Drug Administration ...Read more

  • Glenmark receives approval from Russia to market Montlezir

    Pharma/BioPharma |  News | 0 Comment | 30 Sep, 2019

    Glenmark Pharmaceuticals has announced the approval from the Ministry of Healthcare, Russia to market Montlezir (Levocetirizine Dihydrochloride 5mg + Montelukast Sodium 10mg) film-coated ta...Read more

  • Strides receives USFDA approval for Solifenacin Succinate tablets

    Pharma/BioPharma |  News | 0 Comment | 27 Sep, 2019

    Strides Pharma Science Limited (Strides) has announced that its step‐down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore,  has received approval for Solifenac...Read more

  • Cipla launches Daptomycin for Injection

    Pharma/BioPharma |  News | 0 Comment | 26 Sep, 2019

    Cipla Limited and its subsidiary Cipla USA, Inc., (hereafter referred to as “Cipla”), The pharmaceuticals and drug company, announce the launch of Daptomycin for Injection, 500m...Read more

  • AstraZeneca receives DCGI approval for type 2 diabetes drug

    Pharma/BioPharma |  News | 0 Comment | 26 Sep, 2019

    AstraZeneca Pharma India Limited (AstraZeneca India) announced that it has received Import & Market permission for QTERN® (Fixed dose combination of Dapagliflozin 10mg + Saxagl...Read more

  • Laurus Labs acquires subsidiary of Aspen Pharmacare

    Pharma/BioPharma |  News | 0 Comment | 25 Sep, 2019

    Hyderabad based Laurus Labs Limited, a leading research and development driven pharmaceutical company, is pleased to announce that it has agreed to acquire 100% shares of Phekolong Pharmace...Read more

  • Rybelsus by Novo Nordisk gets USFDA approval

    Pharma/BioPharma |  News | 0 Comment | 23 Sep, 2019

    Novo Nordisk has announced that the USFDA approval for Rybelsus® (semaglutide tablets), as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes me...Read more

  • Dr. Reddy’s launches OTC Lansoprazole capsule in the U.S. market

    Pharma/BioPharma |  News | 0 Comment | 23 Sep, 2019

    Dr. Reddy’s Laboratories Ltd. has announced the launch of Lansoprazole Delayed-Release Capsules USP, 15 mg, an over-the-counter (OTC) store-brand equivalent of Prevacid® 24HR Caps...Read more

  • Eisai Pharma and Mylan collaborate to promote, distribute eribulin

    Pharma/BioPharma |  News | 0 Comment | 23 Sep, 2019

    Eisai Co., Ltd. based in Tokyo, announced that Eisais subsidiary Eisai Pharmaceuticals India Pvt. Ltd. (Location: Andhra Pradesh,Eisai India) and Mylan N. V. (Headquarters: Pennsylvania, Un...Read more

  • Lupin receives sANDA approval for Levothyroxine Sodium Tablets

    Pharma/BioPharma |  News | 0 Comment | 20 Sep, 2019

    Lupin has announced that it has received approval for its sANDA for Levothyroxine Sodium Tablets USP, 25 mcg, 50 mcg, 75 mcg, 88 mcg, 100 mcg, 112 mcg, 125 mcg, 137 mcg, 150 mcg, 175 mcg, 2...Read more

  • AstraZeneca strengthens partnership with NASSCOM to fight NCDs

    Pharma/BioPharma |  News | 0 Comment | 20 Sep, 2019

    A day-long flagship health-tech event of NASSCOM, LHIF “Re-defining the Healthcare Landscape - The Digital Shift”, was inaugurated on 19th Sept by some of the leading names in t...Read more

  • Glenmark receives ODD for Multiple Myeloma drug

    Pharma/BioPharma |  News | 0 Comment | 17 Sep, 2019

    Glenmark Pharmaceuticals has announced that the USFDA has granted Orphan Drug Designation to its bispecific antibody candidate GBR 1342 for the treatment of patients with multiple myeloma w...Read more

  • Biocon to enter Greater China market

    Pharma/BioPharma |  News | 0 Comment | 12 Sep, 2019

    Biocon Ltd, Asia’s premier biopharmaceuticals company, has announced that it has signed a License and Supply Agreement with a subsidiary of China Medical System Holdings Ltd. (CMS) fo...Read more

  • IIL hosts Cabinet Minister Giriraj Singh

    Pharma/BioPharma |  News | 0 Comment | 11 Sep, 2019

    Indian Immunologicals Limited (IIL), a leading biologicals company in India, hosted Giriraj Singh, Cabinet Minister for Animal Husbandry, Dairying and Fisheries, Government o...Read more